PRESSEMITTEILUNGEN

Hatfield, Grossbritannien (ots/PRNewswire) – Eisai hat heute die Präsentation von zehn Abstracts auf der 47. Jahrestagung der American Society of Clinical Oncology (ASCO) angekündigt, die vom 3. bis 7. Juni 2011 in Chicago stattfindet. Darin werden die Ergebnisse neuer Studien zu Schilddrüsen- und metastasiertem Brustkrebs, Ovarialkarzinom und anderen Krebsarten vorgestellt. Die Studien geben einen Einblick [...]

Continue reading

Asco, Eisai Inc, Grossbritannien, Hatfield, Human Health Care, Krebs, Melanoma, Oncology, Oral Session, Ots, Owa, Poster Presentation, Prnewswire, Product Creation, Radioiodine, Takashi, Thyroid Cancer, Tki, Type Melanoma, Tyrosine Kinase

Uithoorn, Netherlands, November 24 (ots/PRNewswire) – From 27 September until 1 October HOYA Vision Care invited a selection of its best lens experts and VIP customers from all over the world to join its Global PAL Summit in La Toja, Spain. Goal was to discuss in depth new technological developments and share vision and plans [...]

Continue reading

Future Generation, Global Level, Individual Solutions, La Toja, Lens Design, Lens Designers, Marijn, New Vigor, Optical Lens, Opticians, Poster Presentation, Prnewswire, Progressive Lens, Progressive Lenses, Share Vision, Technological Developments, Vip Customers, Vision Care, Vision Future, Winter Telephone

Independent validation of laboratory test used in PRESEPT Study shows that the test finds 86% of the cancers ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/Molecular diagnostics Subtitle: Independent validation of laboratory test used in PRESEPT Study shows that the test finds [...]

Continue reading

Barcelona Spain, Benchmark Study, Biomarker, Cancer Cases, Cancer Detection, Cancer Diagnostics, Colonoscopy, Colorectal, Colorectal Cancer Screening, Company Announced That, Discoverer, Epigenomics, European Gastroenterology, Independent Validation, Laboratory Test, Medical Affairs, Molecular Diagnostics, Poster Presentation, Prospective Evaluation, Senior Vice President

Presentation at ASCO – NCI – EORTC Molecular Markers Meeting ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/Molecular diagnostics Subtitle: Presentation at ASCO – NCI – EORTC Molecular Markers Meeting Berlin and Seattle – October 20, 2010 (euro adhoc) – Epigenomics AG’s [...]

Continue reading

Arup Laboratories, Biomarker, Cancer Cases, Clinical Validation, Colorectal Cancer, Dna Methylation, Ecx, Epigenomics Ag, Free Dna, Hollywood Fl, Independent Validation, Laboratory Service, Molecular Diagnostics, Molecular Markers, Poster Presentation, Premalignant Lesions, Prime Standard, Supportive Tissue, Validation Results, Validation Study

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/Molecular diagnostics Berlin and Seattle, October 18, 2010 (euro adhoc) – ARUP Laboratories, Salt Lake City, UT, USA, a licensee of Epigenomics, will present clinical data validating ARUP’s laboratory-developed test for the detection of methylated [...]

Continue reading

Abstract Id, Abstract Title, Arup Laboratories, Blood Plasma, Cancer Colorectal, Cancer Conference, Cancer Diagnostics, Colorectal Cancer Patients, Diplomat Hotel Hollywood, Diplomat Hotel Hollywood Fl, Eortc, Epigenomics, Fl Usa, Molecular Markers, Poster Presentation, Poster Session, Presentation Details, Salt Lake City, Westin Diplomat Hotel, Westin Diplomat Hotel Hollywood Fl

Huntington Beach, California and Amsterdam, June 4, 2010 (ots/PRNewswire) – Agendia, a world leader in molecular cancer diagnostics, today announced that researchers from Agendia and leading academic centers in the U.S. and Europe will present data from multiple studies concerning Agendia’s assays MammaPrint(R), BluePrint(TM), and ColoPrint(TM) at the American Society of Clinical Oncology Annual Meeting, [...]

Continue reading

Academic Centers, Breast Cancer, Breast Cancer Recurrence, Breast Cancers, Cancer Diagnostics, Cancer Test, Colon Cancer, Colorectal Cancers, Docetaxel, Fda Clearance, Huntington Beach California, Inflammatory Breast Cancer, Mccormick Place In Chicago, Molecular Cancer, Patient Safety Issues, Poster Presentation, Prnewswire, S Hall, Snoo, Trastuzumab

mSEPT9 biomarker facilitates innovative blood test for colorectal cancer mSEPT9 data published in Clinical Chemistry PRESEPT Study for colorectal cancer screening with mSEPT9 well on track ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– new product/research/Molecular diagnostics Press release, Berlin, Germany, and Seattle, WA, [...]

Continue reading

Biomarker, Cancer Detection, Cancer Screening, Case Control Studies, Clinical Chemistry, Clinical Validation, Colorectal Cancer, Ddw, Digestive Disease Week, Dna Methylation, Dr Catherine, Eans, Epigenomics Ag, Gastroenterologists, Molecular Biology, Molecular Diagnostics, New Product Research, Poster Presentation, Prestigious Conference, Seattle Wa Usa

Biomarker mPITX2 for prostate cancer prognostic application successfully validated First clinical laboratory in Germany to start offering mPITX2 testing service ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– new product/research/Molecular diagnostics Press release, Berlin, Germany and Seattle, WA, USA, May 29, 2009 (euro adhoc) [...]

Continue reading

Berlin Germany, Cancer Detection, Disease Recurrence, Dna Methylation, Eans, Epigenomics Ag, Molecular Diagnostics, New Product Research, Orlando Florida Usa, Poster Presentation, Prime Standard, Prostate Cancer, Prostate Cancer Patients, Prostate Cancer Prognosis, Prostate Cancer Risk, Prostatectomy, Rational Design, Risk Groups, Seattle Wa Usa, Validation Study